Advanced Respiratory, Inc., headquartered in the United States, is a leading player in the respiratory care industry, specialising in innovative solutions for patients with chronic respiratory conditions. Founded in the early 2000s, the company has established a strong presence across major operational regions, focusing on the development of advanced medical devices and therapies. The core offerings of Advanced Respiratory include state-of-the-art nebulisers, oxygen delivery systems, and airway clearance devices, all designed to enhance patient outcomes and improve quality of life. What sets them apart is their commitment to research and development, ensuring that their products incorporate the latest technological advancements. With a reputation for excellence, Advanced Respiratory has achieved significant milestones, positioning itself as a trusted name in respiratory care. Their dedication to patient-centric solutions continues to drive their success in a competitive market.
How does Advanced Respiratory, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Advanced Respiratory, Inc.'s score of 46 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Advanced Respiratory, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Baxter International Inc., which may influence its climate commitments and reporting practices. While Advanced Respiratory, Inc. has not established its own reduction targets or climate pledges, it is important to note that emissions data and performance metrics may be inherited from Baxter International Inc. at a cascade level of three. This means that any climate initiatives or targets set by Baxter could potentially impact Advanced Respiratory's environmental strategies. As of now, Advanced Respiratory, Inc. has not publicly committed to specific science-based targets or initiatives such as those outlined by the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The absence of defined reduction targets suggests that the company may still be in the early stages of developing its climate strategy. In summary, while Advanced Respiratory, Inc. does not currently report emissions data or specific climate commitments, its relationship with Baxter International Inc. may provide a framework for future sustainability initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2014 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 781,365,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Advanced Respiratory, Inc.'s Scope 3 emissions, which decreased by 10% last year and decreased by approximately 7% since 2009, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 45% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Advanced Respiratory, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.